Antimalarial synergy of cysteine and aspartic protease inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 9, 1998, Pages 2254-2258

  Semenov, Andrey ^a   Olson, Jed E ^a   Rosenthal, Philip J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; ASPARTIC PROTEINASE INHIBITOR; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; HEMOGLOBIN;

ANIMAL MODEL; ARTICLE; DEGRADATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; MALARIA; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031691453     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.9.2254     Document Type: Article

References (22)

1. Bailly, E., R. Jambou, J. Savel, and G. Jaureguiberry. 1992. Plasmodium falciparum: differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and pepstatin A (aspartyl protease inhibitor). J. Protozool. 39: 593-599.
2. 2 specificity of human cathepsin O2 in comparison with cathepsins S and L. Biochem. J. 315:85-89.
3. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
4. Francis, S. E., I. Y. Gluzman, A. Oksman, A. Knickerbocker, R. Mueller, M. L. Bryant, D. R. Sherman, D. G. Russell, and D. E. Goldberg. 1994. Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J. 13:306-317.
5. Francis, S. E., D. J. Sullivan, and D. E. Goldberg. 1997. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:97-123.
6. Gamboa de Domínguez, N. D., and P. J. Rosenthal. 1996. Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites. Blood 87:4448-4454.
7. Gluzman, I. Y., S. E. Francis, A. Oksman, C. E. Smith, K. L. Duffin, and D. E. Goldberg. 1994. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J. Clin. Investig. 93:1602-1608.
8. Goldberg, D. E., A. F. G. Slater, R. Beavis, B. Chait, A. Cerami, and G. B. Henderson. 1991. Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease. J. Exp. Med. 173:961-969.
9. Kyle, D. E. Personal communication.
10. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
11. Moon, R. P., L. Tyas, U. Certa, K. Rupp, D. Bur, C. Jacquet, H. Matile, H. Loetscher, F. Grueninger-Leitch, J. Kay, B. M. Dunn, C. Berry, and R. G. Ridley. 1997. Expression and characterisation of plasmepsin I from Plasmodium falciparum. Eur. J. Biochem. 244:552-560.
12. Olliaro, P., J. Cattani, and D. Wirth. 1996. Malaria, the submerged disease. JAMA. 275:230-233.
13. Rosenthal, P. J. 1995. Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. Exp. Parasitol. 80: 272-281.
14. Rosenthal, P. J., G. K. Lee, and R. E. Smith. 1993. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. J. Clin. Investig. 91:1052-1056.
15. Rosenthal, P. J., J. H. McKerrow, M. Aikawa, H. Nagasawa, and J. H. Leech. 1988. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J. Clin. Investig. 82:1560-1566.
16. Rosenthal, P. J., and S. R. Meshnick. 1996. Hemoglobin catabolism and iron utilization by malaria parasites. Mol. Biochem. Parasitol. 83:131-139.
17. Rosenthal, P. J., J. E. Olson, G. K. Lee, J. T. Palmer, J. L. Klaus, and D. Rasnick. 1996. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob. Agents Chemother. 40:1600-1603.
18. Rosenthal, P. J., W. S. Wollish, J. T. Palmer, and D. Rasnick. 1991. Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J. Clin. Investig. 88:1467-1472.
19. Salvesen, G., and H. Nagase. 1989. Inhibition of proteolytic enzymes, p. 83-104. In R. J. Beynon and J. S. Bond (ed.), Proteolytic enzymes. IRL Press, Oxford, United Kingdom.
20. Silva, A. M., A. Y. Lee, S. V. Gulnik, P. Majer, J. Collins, T. N. Bhat, P. J. Collins, R. E. Cachau, K. E. Luker, I. Y. Gluzman, S. E. Francis, A. Oksman, D. E. Goldberg, and J. W. Erickson. 1996. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 93:10034-10039.
21. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
22. Walsh, J. A. 1989. Disease problems in the Third World. Ann. N. Y. Acad. Sci. 569:1-16.